FDA.reportPublic FDA data

Furosemide

Product NDC
53217-271
11-digit product format
532170271
Labeler code
53217
Product ID
53217-271_53f94619-b9c5-4655-93ef-d5a409557b55
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Furosemide
Dosage form
TABLET
Route
ORAL
Labeler
Aidarex Pharmaceuticals LLC
Application
ANDA077293
Marketing category
ANDA
Marketing start
2006-02-01
Marketing end
0000-00-00
Substance
FUROSEMIDE
Active strength
20 mg/1
Pharmacologic classes
Increased Diuresis at Loop of Henle [PE],Loop Diuretic [EPC]
NDC exclude flag
No
Listing certified through
2019-12-31
Current FDA listing
Historical FDA.report record

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
d80d3aff-3a63-4d7b-a2be-fd9388b04330Product name920250806
9061e89f-9c86-4196-b34b-886fc1673cc4Product name120140821

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
53217-271-002020-01-31C16284748780-19d75b9d0-d9b7-f424-e053-dadaa90a57ceFUROSEMIDE TABLETS, USP
53217-271-082020-01-31C16284748780-19d75b9d0-d9b7-f424-e053-dadaa90a57ceFUROSEMIDE TABLETS, USP
53217-271-142020-01-31C16284748780-19d75b9d0-d9b7-f424-e053-dadaa90a57ceFUROSEMIDE TABLETS, USP
53217-271-202020-01-31C16284748780-19d75b9d0-d9b7-f424-e053-dadaa90a57ceFUROSEMIDE TABLETS, USP
53217-271-302020-01-31C16284748780-19d75b9d0-d9b7-f424-e053-dadaa90a57ceFUROSEMIDE TABLETS, USP
53217-271-602020-01-31C16284748780-19d75b9d0-d9b7-f424-e053-dadaa90a57ceFUROSEMIDE TABLETS, USP
53217-271-902020-01-31C16284748780-19d75b9d0-d9b7-f424-e053-dadaa90a57ceFUROSEMIDE TABLETS, USP

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
53217-271-00Furosemide100 in 1 BOTTLETABLET1003
53217-271-08Furosemide8 in 1 BOTTLETABLET83
53217-271-14Furosemide14 in 1 BOTTLETABLET143
53217-271-20Furosemide20 in 1 BOTTLETABLET203
53217-271-30Furosemide30 in 1 BOTTLETABLET303
53217-271-60Furosemide60 in 1 BOTTLETABLET603
53217-271-90Furosemide90 in 1 BOTTLETABLET903

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
53217-271-00EA - Each53217-271797572a9-ab33-4971-8a91-7ca0eb21b51812017-05-04
53217-271-08EA - Each53217-271ccbd2cb4-a32b-4764-9f77-8e72879fbe2012017-05-04
53217-271-14EA - Each53217-271112ea946-6578-44a2-9280-5dad1caf613812017-05-04
53217-271-20EA - Each53217-27143c1d7a0-b732-4334-b35b-a51c1ad6a5fa12017-05-04
53217-271-30EA - Each53217-27126200570-0747-449c-9d5b-fcffd490a50912017-05-04
53217-271-60EA - Each53217-27186fcd991-2e3a-46f1-b61c-14c52d9176ff12017-05-04
53217-271-90EA - Each53217-27121318f13-22ba-4733-b0e7-e8ebff87c4e112017-05-04

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
53217-271FUROSEMIDE TABLET [AIDAREX PHARMACEUTICALS LLC]3Legacy NDC, 7 package rows20170413_e44cc8ac-1e04-4910-bde1-1f4a45a6937f.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
310429furosemide 20 MG Oral TabletPSNe44cc8ac-1e04-4910-bde1-1f4a45a6937f3
313988furosemide 40 MG Oral TabletPSNe44cc8ac-1e04-4910-bde1-1f4a45a6937f3
310429furosemide 20 MG Oral TabletSCDe44cc8ac-1e04-4910-bde1-1f4a45a6937f3
313988furosemide 40 MG Oral TabletSCDe44cc8ac-1e04-4910-bde1-1f4a45a6937f3

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionStatus
53217-271-0053217027100100 in 1 BOTTLEHistorical
53217-271-08532170271088 in 1 BOTTLEHistorical
53217-271-145321702711414 in 1 BOTTLEHistorical
53217-271-205321702712020 in 1 BOTTLEHistorical
53217-271-305321702713030 in 1 BOTTLEHistorical
53217-271-605321702716060 in 1 BOTTLEHistorical
53217-271-905321702719090 in 1 BOTTLEHistorical